48. Primary antiphospholipid syndrome Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 5 Drugs : 6 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathways : 7

Drugs and their primary sponsors and trial info
EPA and DHA supplementation   
   University of Sao Paulo
      2014   -   NCT01956188   Brazil;
Hydroxychloroquine   
   National and Kapodistrian University of Athens
      2013   -   NCT04153201   Greece;
   University Hospital, Angers
      2018   Phase 3   NCT03540810   France;
Telitacicept   
   Peking Union Medical College Hospital
      2021   Phase 2   NCT05078710   China;